The Swiss life-sciences company said it expected accelerated sales growth in the fourth quarter on the back of the timing of product releases and the ramp-up of its new acquired manufacturing facility, and confirmed its guidance for the full year.
Related Posts
Universal Music Sheds $16 Billion in Market Cap After Revenues Disappoint
The record label behind Taylor Swift, Billie Eilish and Ariana Grande posted revenue growth from subscriptions and streaming services well below what analysts had expected.
Novartis Lifts Sales Outlook on Key Drugs, Pipeline Portfolio
The pharma company raised its guidance on revenue growth from its key treatments and expected drug launches, and now anticipates annual currency-adjusted sales to grow […]
America’s New Millionaire Class: Plumbers and HVAC Entrepreneurs
Private equity is pouring money into skilled-trade small businesses; ‘Next thing you know, you’re running an empire.’